Skip to main content

ACTICON

Dosage form: tablet
Ingredients: DEXBROMPHENIRAMINE MALEATE 2mg, PSEUDOEPHEDRINE HYDROCHLORIDE 60mg
Labeler: Actipharma, Inc
NDC code: 63102-401

Medically reviewed by Drugs.com. Last updated on Dec 4, 2023.

ACTICON COLD and ALLERGY Tablets

Drug Facts

Active ingredients (in each tablet)

Dexbrompheniramine Maleate, USP 2 mg

Pseudoephedrine HCl, USP 60 mg

Purpose

Antihistamine

Nasal Decongestant

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
• runny nose • sneezing
• itching of the nose or throat
• itchy, watery eyes
• nasal congestion
• reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

• if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have

• a breathing problem such as emphysema or chronic bronchitis
• glaucoma • heart disease
• high blood pressure
• thyroid disease
• diabetes mellitus
• difficulty in urination due to enlargement of the prostate gland

Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.

When using this product
• excitability may occur, especially in children
• may cause drowsiness
• alcohol, sedatives and tranquilizers may increase drowsiness
• avoid alcoholic beverages
• use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if
• nervousness, dizziness, or sleeplessness occur
• if symptoms do not improve within 7 days or are accompanied by fever
• new symptoms occur

If pregnant or breast feeding, ask a health professional before use.

Directions

Do not exceed recommended dosage.

Adults and children 12 years of age and over:1 tablet every 4 to 6 hours not to exceed 4 tablets in 24 hours or as directed by a doctor
Children 6 to under 12 years of age:1/2 tablet every 4 to 6 hours not to exceed 2 tablets in 24 hours or as directed by a doctor
Children under 6 years of ageConsult a doctor

Inactive ingredients

Magnesium stearate, microcrystalline cellulose, sodium starch glycolate

Other information

Store at 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].

Questions or Comments?

Call 787-608-0882

Manufactured in the USA for ActiPharma, Inc. Dorado, PR 00646. Tel: (787) 608-0882

*Conex® Tablets is a registered trademark of Llorens Pharmaceutical Corp. This product is not manufactured, distributed or marketed by Llorens Pharmaceutical Corp.

Contains the same active ingredients as Conex® Tablets*

ANTIHISTAMINE  NASAL DECONGESTANT

Tamper evident by foil seal under cap.

Do not use if foil seal is broken or missing.

Packaging

ACTICON 
dexbrompheniramine maleate, pseudoephedrine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63102-401
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXBROMPHENIRAMINE MALEATE (DEXBROMPHENIRAMINE) DEXBROMPHENIRAMINE MALEATE2 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
SODIUM STARCH GLYCOLATE TYPE A POTATO 
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize13mm
FlavorImprint CodeA401
Contains    
Packaging
#Item CodePackage Description
1NDC:63102-401-6060 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34108/13/2015
Labeler - Actipharma, Inc (079340948)

Revised: 12/2018
 
Actipharma, Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.